FEATURED
Eli Lilly to Invest $6 Billion in New API Manufacturing Facility in Alabama, USA
The new Huntsville, Alabama site will produce small molecule and peptide medicines, including oral GLP-1 orforglipron Eli Lilly and Company
DEALS
Pfizer Strikes Landmark Deal with Trump Administration to Cut Drug Prices for U.S. Patients
Pfizer Inc. has reached a sweeping agreement with the Trump Administration that will reduce prescription drug costs for U.S. patients
PRESS RELEASES
Journal Club: Gene-Agnostic Gene Therapy to Preserve Vision
Striatech is pleased to announce its next Journal Club: Gene-Agnostic Gene Therapy to Preserve Vision, which will be held on
EDITOR’S PICKS
Placing Regulatory Compliance at the Core of Pharmaceutical Supply Chains
Optimising Efficiency with Data Loggers In the fast-paced and highly regulated landscape of the pharmaceutical industry, ensuring compliance with stringent
RESOURCES
Enhancing RPE Metabolism to Protect Cone Vision in Retinitis Pigmentosa
Boosting RPE Metabolic Support Offers a Promising Gene-Independent Strategy for RP Treatment A Striatech .pdf Case Study Retinitis Pigmentosa (RP)
MANUFACTURING PROJECTS
Eli Lilly to Invest $6 Billion in New API Manufacturing Facility in Alabama, USA
The new Huntsville, Alabama site will produce small molecule and peptide medicines, including oral GLP-1 orforglipron Eli Lilly and Company
CLINICAL TRIALS
Lilly’s Jaypirca Outperforms Imbruvica in CLL Head-to-Head Phase 3 Trial
Eli Lilly’s Jaypirca (pirtobrutinib), the first and only FDA-approved non-covalent (reversible) BTK inhibitor, has met its primary endpoint in the
REGULATORY
Merck’s KEYTRUDA QLEX™ Secures FDA Approval as First Subcutaneous Pembrolizumab Injection
Merck & Co., known as MSD outside of the United States and Canada, announced on Saturday that the U.S. Food
SELECTED PRODUCTS
Dual Refrigerated and Deep-Freezer Containers
The Combi range of dual refrigerated and deep-freezer containers is designed to deliver maximum versatility for pharmaceutical and chemical cold
